Search research articles
Contact Us
Filters
Showing results (11-20 of 129) with videos related to
Page
of 13
Sort By:
Onkologie
|
October 8, 2010
Spontaneous pneumothorax during chemotherapy: a case report
Martin Fehr, Roger von Moos, Markus Furrer, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 22, 2016
Combination of cisplatin and lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma: Report of two cases
Yannis Metaxas, Richard Cathomas, Michael Mark, et al.
The Lancet. Oncology
|
September 3, 2013
What can we learn from the ZOOM trial?
Stefanie Hayoz, Dirk Klingbiel, Peter Brauchli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2007
Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma?
Thomas Ruhstaller, Beat Thuerlimann, Dieter Koeberle, et al.
Hematological Oncology
|
September 20, 2016
Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation
Ulrich J M Mey, Christoph Renner, Roger von Moos
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 8, 2013
Reducing the burden of bone metastases: current concepts and treatment options
Roger von Moos, Cora Sternberg, Jean-Jacques Body, et al.
BMC Urology
|
September 22, 2018
Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
Jean-Jacques Body, Roger von Moos, Daniela Niepel, et al.
Journal of the National Cancer Institute
|
December 1, 2021
RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer
Michael Mark, Roger von Moos, Richard Cathomas, et al.
Journal of Gastrointestinal Oncology
|
April 30, 2019
Prolonged tumor response associated with sequential immune checkpoint inhibitor combination treatment and regorafenib in a patient with advanced pretreated hepatocellular carcinoma
Markus Joerger, Ulrich Güller, Sara Bastian, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 30, 2013
A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer
Miklos Pless, Cornelia Droege, Roger von Moos, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 129) with videos related to
Sort By:
Page
of 13
Onkologie
|
October 8, 2010
Spontaneous pneumothorax during chemotherapy: a case report
Martin Fehr, Roger von Moos, Markus Furrer, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 22, 2016
Combination of cisplatin and lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma: Report of two cases
Yannis Metaxas, Richard Cathomas, Michael Mark, et al.
The Lancet. Oncology
|
September 3, 2013
What can we learn from the ZOOM trial?
Stefanie Hayoz, Dirk Klingbiel, Peter Brauchli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2007
Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma?
Thomas Ruhstaller, Beat Thuerlimann, Dieter Koeberle, et al.
Hematological Oncology
|
September 20, 2016
Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation
Ulrich J M Mey, Christoph Renner, Roger von Moos
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 8, 2013
Reducing the burden of bone metastases: current concepts and treatment options
Roger von Moos, Cora Sternberg, Jean-Jacques Body, et al.
BMC Urology
|
September 22, 2018
Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
Jean-Jacques Body, Roger von Moos, Daniela Niepel, et al.
Journal of the National Cancer Institute
|
December 1, 2021
RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer
Michael Mark, Roger von Moos, Richard Cathomas, et al.
Journal of Gastrointestinal Oncology
|
April 30, 2019
Prolonged tumor response associated with sequential immune checkpoint inhibitor combination treatment and regorafenib in a patient with advanced pretreated hepatocellular carcinoma
Markus Joerger, Ulrich Güller, Sara Bastian, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 30, 2013
A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer
Miklos Pless, Cornelia Droege, Roger von Moos, et al.
Page
of 13